What are the risks of having high fasting glucose?

High fasting glucose increases your risk of developing type 2 diabetes, cardiovascular disease, kidney damage, and nerve problems. Even moderately elevated levels can cause oxidative stress and inflammation that damage blood vessels and organs over time.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Fasting Glucose and Its Importance

Fasting glucose measures your blood sugar levels after not eating for at least 8 hours, typically tested first thing in the morning. This biomarker provides crucial insight into how well your body regulates blood sugar when you're not actively digesting food. Normal fasting glucose ranges from 70-99 mg/dL, while levels between 100-125 mg/dL indicate prediabetes, and 126 mg/dL or higher on two separate tests confirms diabetes.

Your body maintains blood sugar through a delicate balance of hormones, primarily insulin and glucagon. When this system becomes impaired, glucose accumulates in your bloodstream instead of being absorbed by cells for energy. This chronic elevation damages blood vessels, nerves, and organs throughout your body, creating a cascade of health complications that can significantly impact your quality of life and longevity.

Immediate Health Risks of Elevated Fasting Glucose

Oxidative Stress and Inflammation

When glucose levels remain elevated, excess sugar molecules attach to proteins in your blood through a process called glycation. This creates harmful compounds called advanced glycation end products (AGEs) that trigger inflammation and oxidative stress. These processes damage the delicate lining of blood vessels, accelerate aging, and interfere with normal cellular function throughout your body.

Fasting Glucose Levels and Associated Health Risks

Glucose Level (mg/dL)CategoryHealth RisksRecommended Actions
70-9970-99 mg/dLNormalMinimal riskAnnual monitoring, maintain healthy lifestyle
100-125100-125 mg/dLPrediabetesIncreased risk of diabetes, cardiovascular disease, kidney damageQuarterly testing, lifestyle intervention, weight loss
126+126+ mg/dLDiabetesHigh risk of all complications: heart disease, neuropathy, retinopathy, kidney failureMedical management, frequent monitoring, comprehensive care

Fasting glucose should be measured after 8+ hours without food. Diagnosis requires confirmation with repeat testing.

Energy Fluctuations and Metabolic Dysfunction

High fasting glucose often indicates insulin resistance, where cells become less responsive to insulin's signal to absorb glucose. This creates a paradox where you have plenty of fuel in your bloodstream but your cells can't access it efficiently. The result is persistent fatigue, difficulty concentrating, increased hunger, and weight gain, particularly around the midsection. These symptoms can significantly impact your daily productivity and overall well-being.

Long-Term Cardiovascular Complications

Elevated fasting glucose dramatically increases your risk of cardiovascular disease through multiple mechanisms. High blood sugar damages the endothelium (inner lining of blood vessels), promoting atherosclerosis and plaque formation. Studies show that people with prediabetes have a 15-30% higher risk of cardiovascular events compared to those with normal glucose levels, while those with diabetes face a 2-4 times higher risk.

The cardiovascular risks associated with high fasting glucose include:

  • Coronary artery disease and heart attacks
  • Stroke and transient ischemic attacks
  • Peripheral artery disease affecting circulation to limbs
  • Heart failure due to diabetic cardiomyopathy
  • Hypertension from damaged blood vessels
  • Abnormal cholesterol profiles with elevated triglycerides and reduced HDL

Regular monitoring of both glucose and cardiovascular biomarkers provides a comprehensive picture of your metabolic health. Understanding how these systems interact helps you take targeted action to reduce your risk.

Kidney and Nerve Damage Risks

Diabetic Nephropathy

Your kidneys filter about 180 liters of blood daily, and high glucose levels damage the delicate filtering units called nephrons. Over time, this leads to diabetic nephropathy, the leading cause of kidney failure in developed countries. Early stages show no symptoms, but protein in the urine (microalbuminuria) signals developing damage. Without intervention, this progresses to chronic kidney disease requiring dialysis or transplantation.

Peripheral Neuropathy

Chronic high blood sugar damages nerve fibers throughout your body, particularly in your feet and hands. This peripheral neuropathy affects up to 50% of people with diabetes, causing numbness, tingling, burning pain, and loss of sensation. The loss of protective sensation increases injury risk and can lead to serious complications like foot ulcers and amputations. Early detection and glucose control can prevent or slow progression.

Understanding your fasting glucose levels helps identify these risks early.

Vision and Cognitive Health Impacts

High fasting glucose threatens your vision through diabetic retinopathy, where damaged blood vessels in the retina leak fluid or bleed. This condition develops silently and is the leading cause of blindness in working-age adults. Regular eye exams and glucose control are essential, as early stages are treatable but advanced damage is irreversible.

Emerging research reveals concerning links between elevated glucose and cognitive decline. High blood sugar accelerates brain aging, increases Alzheimer's disease risk by up to 65%, and impairs memory formation. The brain relies heavily on glucose for energy, but chronically elevated levels create inflammation and vascular damage that compromise cognitive function. Studies show that even prediabetic glucose levels can affect memory and processing speed.

Cancer and Immune System Risks

Elevated fasting glucose creates an environment that promotes cancer development and progression. Cancer cells preferentially use glucose for rapid growth, and high insulin levels (common with insulin resistance) act as growth factors. Research shows increased risks for colorectal, breast, endometrial, pancreatic, and liver cancers in people with chronically elevated glucose. The risk increases progressively with higher glucose levels, even within the prediabetic range.

Your immune system also suffers when glucose runs high. White blood cells function poorly in high-sugar environments, reducing their ability to fight infections. People with elevated glucose experience more frequent and severe infections, slower wound healing, and increased susceptibility to fungal infections. This compromised immunity creates additional health vulnerabilities beyond the direct effects of high glucose.

Monitoring and Prevention Strategies

Early detection of rising fasting glucose allows intervention before serious complications develop. Key monitoring approaches include:

  • Annual fasting glucose tests starting at age 35, or earlier with risk factors
  • HbA1c testing to assess average glucose over 3 months
  • Continuous glucose monitoring for detailed patterns
  • Regular lipid panels to assess cardiovascular risk
  • Kidney function tests including microalbumin
  • Comprehensive metabolic panels for overall health assessment

Prevention focuses on lifestyle modifications that improve insulin sensitivity and glucose metabolism. Maintaining a healthy weight reduces insulin resistance by up to 58%. Regular physical activity, particularly strength training and aerobic exercise, enhances glucose uptake by muscles. A Mediterranean-style diet rich in whole foods, healthy fats, and fiber helps stabilize blood sugar. Adequate sleep (7-9 hours) and stress management also play crucial roles in glucose regulation.

For comprehensive metabolic health monitoring that includes fasting glucose along with other critical biomarkers, regular testing provides the insights needed to track progress and adjust your prevention strategies.

Taking Action on Your Glucose Health

High fasting glucose represents a critical warning sign that demands attention. The progression from normal glucose to prediabetes to diabetes isn't inevitable—it's a process you can interrupt with informed action. Every mg/dL reduction in fasting glucose translates to measurable decreases in complication risks. Studies show that reducing fasting glucose by just 10 mg/dL can lower cardiovascular event risk by 12-14%.

The key lies in early detection and consistent monitoring. By understanding your glucose patterns and how they respond to lifestyle changes, you gain the power to prevent or reverse metabolic dysfunction. Whether through dietary modifications, increased physical activity, stress reduction, or medical intervention when necessary, you have multiple tools to optimize your glucose levels and protect your long-term health.

References

  1. American Diabetes Association. (2023). Standards of Medical Care in Diabetes-2023. Diabetes Care, 46(Supplement 1), S1-S267.[Link][DOI]
  2. Huang, Y., Cai, X., Mai, W., Li, M., & Hu, Y. (2016). Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ, 355, i5953.[Link][PubMed][DOI]
  3. Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012). Prediabetes: a high-risk state for diabetes development. The Lancet, 379(9833), 2279-2290.[Link][PubMed][DOI]
  4. Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A., & Nathan, D. M. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393-403.[Link][PubMed][DOI]
  5. Biessels, G. J., & Despa, F. (2018). Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nature Reviews Endocrinology, 14(10), 591-604.[Link][PubMed][DOI]
  6. Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., ... & Yee, D. (2010). Diabetes and cancer: a consensus report. Diabetes Care, 33(7), 1674-1685.[Link][PubMed][DOI]

Frequently Asked Questions

How can I test my fasting glucose at home?

You can test your fasting glucose at home with SiPhox Health's Heart & Metabolic Program, which includes fasting glucose testing along with comprehensive cardiovascular and metabolic biomarkers. The program provides CLIA-certified lab results from a simple at-home blood draw.

What's the difference between fasting glucose and HbA1c?

Fasting glucose measures your blood sugar at a single point in time after not eating for 8+ hours, while HbA1c reflects your average blood sugar over the past 2-3 months. Fasting glucose can fluctuate daily based on stress, sleep, and recent meals, whereas HbA1c provides a more stable long-term picture of glucose control. Both tests are important for comprehensive metabolic assessment.

Can high fasting glucose be reversed?

Yes, elevated fasting glucose can often be reversed, especially in the prediabetic range (100-125 mg/dL). Weight loss of 5-10% of body weight, regular physical activity, and dietary changes can restore normal glucose levels. Studies show that intensive lifestyle interventions can reduce diabetes risk by 58% in people with prediabetes. The earlier you intervene, the better your chances of complete reversal.

What symptoms indicate my fasting glucose might be high?

High fasting glucose often has no obvious symptoms initially, which is why testing is crucial. When symptoms do occur, they may include increased thirst and urination, fatigue despite adequate sleep, blurred vision, slow wound healing, frequent infections, and tingling in hands or feet. However, many people have elevated levels for years without noticeable symptoms, allowing damage to accumulate silently.

How often should I check my fasting glucose?

If your fasting glucose is normal (under 100 mg/dL) and you have no risk factors, annual testing is typically sufficient. With prediabetes or risk factors like family history, obesity, or PCOS, testing every 3-6 months helps track trends. If you're actively working to improve your glucose levels through lifestyle changes, quarterly testing allows you to monitor progress and adjust your approach based on results.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details